跳至主要内容
临床试验/NCT03606109
NCT03606109已完成4 期

Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2018年6月26日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
58
试验地点
1
主要终点
Perioperative Blood Loss

研究概览

简要总结

The purpose of the proposed study is to evaluate the effects of administering intravenous tranexamic acid (TXA) to patients undergoing high tibial osteotomy (HTO) and tibial tubercle osteotomy (TTO) to minimize hemarthrosis within the knee joint and post operative pain and swelling.

详细描述

Not Provided

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing TTO
  • Age 18-60
  • Willing and able to provide consent

排除标准

  • Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects, dementia, etc.)
  • Younger than 18 years of age
  • Older than 60 years of age
  • Any patient considered a vulnerable subject
  • Have bleeding or clotting disorder
  • Preoperative anticoagulation therapy
  • Abnormal coagulation profile
  • Renal disorder or insufficiency
  • Sickle cell disease

研究组 & 干预措施

High Tibial Osteotomy (HTO)

Active Comparator

干预措施: Tranexamic Acid (TXA) (Drug)

Tibial Tubercle Ostetomy (TTO)

Active Comparator

干预措施: Tranexamic Acid (TXA) (Drug)

结局指标

主要结局

Perioperative Blood Loss

时间窗: Perioperative, up to 2 hours

次要结局

  • Score on Visual Analogue Scale (VAS) for Pain(Day 7)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Reducing Hemarthrosis in Tibial Tubercle Osteotomy... | 临床试验